Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?

by Przemyslaw J. Kotyla
Published 2018-01-01

Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?

by Przemyslaw J. Kotyla
Published 2018-06-01

MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS)

by Przemysław J. Kotyla, Md Asiful Islam
Published 2020-03-01

Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis

by Przemysław J. Kotyla, Md Asiful Islam, Małgorzata Engelmann
Published 2020-10-01

Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review

by Md Asiful Islam, Shahad Saif Khandker, Przemysław J. Kotyla, Rosline Hassan
Published 2020-07-01

Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?

by Przemysław J. Kotyla, Małgorzata Engelmann, Joanna Giemza-Stokłosa, Bartosz Wnuk, Md Asiful Islam
Published 2021-02-01

Fibroblast Growth Factor 23 to Alpha-Klotho Index Correlates with Systemic Sclerosis Activity: A Proposal for Novel Disease Activity Marker

by Przemyslaw J. Kotyla, Aneta Kruszec-Zytniewska, Aleksander J. Owczarek, Magdalena Olszanecka-Glinianowicz, Jerzy Chudek
Published 2018-12-01

Cytometric Characterization of Main Immunocompetent Cells in Patients with Systemic Sclerosis: Relationship with Disease Activity and Type of Immunosuppressive Treatment

by Olga Gumkowska-Sroka, Krystyna Jagoda, Aleksander Owczarek, Grzegorz Helbig, Joanna Giemza-Stokłosa, Przemysław J. Kotyla
Published 2019-05-01

Prevalence of antiphospholipid antibodies in Behçet's disease: A systematic review and meta-analysis.

by Md Asiful Islam, Sayeda Sadia Alam, Shoumik Kundu, A H M Safayet Ullah Prodhan, Shahad Saif Khandker, Tatiana Reshetnyak, Przemysław J Kotyla, Rosline Hassan, Tareq Hossan
Published 2020-01-01